| Name: | Anastrozole EP Impurity I |
| Catalogue No. | VL2490013 |
| CAS No. | 120511-91-3 |
| Molecular Formula | C15H17ClN2 |
| Molecular Weight | 260.76 |
| Status | In-stock |
| IUPAC Name | 2,2′-[5-(Chloromethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile) |
| Description | Anastrozole EP Impurity I (CAS No: 120511-91-3) or 2,2′-[5-(Chloromethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile), Anastrozole EP Impurity I is an impurity of Anastrozole, it is used in the treatment of postmenopausal women with estrogen-responsive breast cancer by decreasing circulating estrogen levels. |
| References | Gangadhara, Sharath, and Gianfilippo Bertelli. “Long-Term Efficacy and Safety of Anastrozole for Adjuvant Treatment of Early Breast Cancer in Postmenopausal Women.” Therapeutics and Clinical Risk Management, vol. 5, 2009, pp. 291–300, www.ncbi.nlm.nih.gov/pmc/articles/PMC2690973/. |
